With help from NIA, biotechnology company Juvena Therapeutics has begun unlocking the secrets of proteins for regenerative medicine. Juvena scientists are using a form of muscular dystrophy — myotonic dystrophy type 1 — as a model to sift through proteins that are produced by the body’s stem cells.
[National Institute of Aging]